Sanofi India's Q1 financial performance shows a significant improvement, with both revenue and net profit surging by 33% and 36% year-on-year respectively. The strong growth is primarily attributed to a 15.5% increase in domestic sales within the Consumer Healthcare sector.

Sanofi India reports a significant increase in Q4 net profit by 36%, reaching ₹678M, and a surge in revenue by 35% to ₹2.3B, indicating robust growth for the company's consumer healthcare division.